Portfolio company
Cellbyte
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Cellbyte develops an artificial intelligence platform to automate pricing, market access and regulatory workflows for pharmaceutical companies to accelerate global drug launches.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Regunaut
Regunaut develops an AI-driven platform that automates regulatory compliance and lifecycle planning for pharmaceutical companies and regulatory affairs teams.
Phluence
Phluence develops an agentic AI workflow platform that automates patient engagement and medicine access services for pharmaceutical manufacturers and healthcare providers.
Form Bio
This company provides a software platform using artificial intelligence to help biopharmaceutical organisations and researchers design and optimise cell and gene therapies.
Metly
This company develops an artificial intelligence platform to automate market opportunity detection and partnership management for pharmaceutical business development teams.
BrandLaunch X
BrandLaunch X develops an AI-powered orchestration platform to help biotechnology and pharmaceutical companies commercialise and launch approved medical therapies.
CellRep
CellRep develops an artificial intelligence platform discovering small molecules that rejuvenate immune cells for developers of cell therapies and regenerative medicine.
PillPilot
PillPilot develops artificial intelligence software to automate prescription data entry and patient communications for pharmacies.
Peer AI
This company develops an artificial intelligence platform to automate regulatory documentation for pharmaceutical, biotechnology and clinical research organisations.
